Neofytos, Dionysios http://orcid.org/0000-0001-6970-2869
Garcia-Vidal, Carolina
Lamoth, Frédéric
Lichtenstern, Christoph
Perrella, Alessandro
Vehreschild, Jörg Janne
Article History
Received: 6 January 2020
Accepted: 4 March 2021
First Online: 24 March 2021
Declarations
:
: Not applicable.
: Not applicable.
: DN has received honoraria for participating in advisory boards and acting as consultant for Gilead Science, Merck Sharp and Dohme, Pfizer, and Astellas and a grant support from Merck Sharp and Dohme.CG-V has received honoraria for talks on behalf of Gilead Science, Merck Sharp and Dohme, Pfizer, Jannsen, Novartis, Lilly and a grant support from Gilead Science and Merck Sharp and Dohme. She has received a research grant from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III [FIS PI18/01061] and a European Regional Development Fund (EDRD) and the INTENSIFICACIÓ Grant- a grant by the Catalan Health Agency [PERIS (Pla estratègic de recerca i innovació en salut – “Strategic Plan for Research and Innovation in HealthCare”)]. FL has received honoraria for participating to advisory boards from MSD, Basilea and Gilead. CL has received personal fees from Merck/MSD, Gilead, Pfizer, and Astellas Pharma. AP has received honoraria for an expert meeting on behalf of Gilead Science. JJV has received personal fees from Merck/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, Deutsches Zentrum für Infektionsforschung, Uniklinik Freiburg / Kongress und Kommunikation, Akademie für Infektionsmedizin, University of Manchester, Deutsche Gesellschaft für Infektiologie, Ärztekammer Nordrhein, Uniklinik Aachen, Back Bay Strategies, Deutsche Gesellschaft für Innere Medizin and grants from Merck/MSD, Gilead, Pfizer, Astellas Pharma, Basilea, Deutsches Zentrum für Infektionsforschung, and Bundesministerium für Bildung und Forschung.